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This study was designed to detect the relation between serum progesterone and viability of pregnancy during the
first trimester. Prospective study carried out in Al-Rashid Maternity and Ahmadi Kuwait oil company hospitals, over
three years from February 2009 to February 2012. Two hundred and Sixty (260) pregnant women were hospitalized
due to vaginal bleeding and/or abdominal pain during the first trimester of their pregnancies and were included in
this study. Women included in this study were; sure of dates, conceived spontaneously with no history of infertility
and had a positive serum pregnancy test. 2 ml blood samples were taken for women included in this study for
serum progesterone assay. Women included in this study were followed by ultrasound for the viability of the
pregnancy till the end of first trimester and the outcome of their pregnancy were recorded, while women with
exogenous progesterone support or multiple pregnancies or suspected ectopic pregnancy or Hydatiform mole
were excluded from this study. Data were collected and statistically analyzed to detect the relationship between
serum progesterone level and viability of pregnancy during the first trimester. The mean age of the studied
population was 32.7 ± 5.1 years, the mean gestational age at progesterone assay was 9.7 ± 0.5 week and by the end
of the first trimester, women included in this study were classified according to the viability of their pregnancies
into; viable pregnancy group 178 (68.5%) cases and non-viable pregnancy group (ended by miscarriage) 82 (31.5%)
cases. The mean serum progesterone of the studied population was significantly high in viable pregnancy group
(46.5 ± 7.4 ng/ml) compared to non-viable pregnancy group (9.9 ± 4.8 ng/ml), (p <0.05). In this study; 6.7% of viable
pregnancies had serum progesterone level <10 ng/ ml, while 20.7% of non-viable pregnancies had serum
progesterone level >10 ng/ml, the serum progesterone at cut off level 10 ng/ml was 79.3% sensitive to diagnose
non-viable pregnancy and was 93.3% specific to diagnose viable pregnancy. Also, in this study; 1.1% of viable
pregnancies had serum progesterone level <20 ng/ ml, while 4.8% of non-viable pregnancies had serum
progesterone level >20 ng/ml, the serum progesterone at cut off level 20 ng/ml was 95.1% sensitive to diagnose
non-viable pregnancy and was 98.9% specific to diagnose viable pregnancy. Serum progesterone is a reliable
marker for early pregnancy failure and single assay of its serum level can differentiate between viable and
non-viable pregnancies.
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Ultrasound scanning is probably the best single diagnos-
tic and prognostic test available for diagnosing early
pregnancy failure. However, there were certain condi-
tions where both sonographic and clinical findings were
indeterminate or inconclusive (Elson et al. 2003).
Progesterone is a C-21 steroid hormone secreted by
granulosa cells of the ovary. This hormone is important* Correspondence: dr.ibrahimanwar@gmail.com
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in any medium, provided the original work is pto promote endometrial decidualization by preparing the
uterus for implantation of the blastocyst and to maintain
the pregnancy (Hanita & Hanisah 2012). The physio-
logical functions of progesterone include; inhibition of
smooth muscle contractility and inhibition of immune
responses like those involved in graft rejection (Hanita
& Hanisah 2012).
Recent studies suggest that serum progesterone mea-
sured in early pregnancy is the most powerful single pre-
dictor of pregnancy outcome in natural conceptions
(Elson et al. 2003). Few studies have attempted to useis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 The characteristics of the studied population
Variables Mean ± SD Range
Age (Year) 32.7 ± 5.1 18 - 38
Parity 4.2 ± 5.7 0 - 9
Gestational age at progesterone assay (Weeks) 9.7 ± 0.5 7 - 11
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pregnancy in IVF/ICSI or in natural pregnancies and
none has produced convincing conclusions (Homan
et al. 2000). It is essential to study women after natural
conceptions without exogenous progesterone support,
when the relation between serum progesterone and
viability of the first trimester pregnancy was evaluated
(Vicdan & Zeki Isik 2001; Zainab Ali Abdulla Al 2000).
So, this prospective study was designed to detect the re-
lation between serum progesterone and viability of the
pregnancy during the first trimester.
Patients & methods
This study was carried out in Al-Rashid Maternity and
Ahmadi Kuwait Oil Company hospitals, over 3 years
from February 2009 to February 2012. Two hundred and
Sixty (260) women were hospitalized due to vaginal
bleeding and/or abdominal pain during the first trimes-
ter of their pregnancies and were included in this pro-
spective study after informed consent and approval of
the study protocol by institute ethical committee of both
hospitals.
Data were collected from women included in this
study by direct questioner to detect; age, parity, gesta-
tional age (calculated from the 1st day of LMP) and past
history of early pregnancy miscarriages. Women
included in the study were; sure of dates, conceived
spontaneously with no history of infertility and had a
positive serum pregnancy test.
2 ml blood samples were taken from women included
in this study for serum progesterone assay and the sam-
ples were collected without anticoagulant in dry tubes.
Serum was separated by centrifugation and stored at
2-8°C until hormonal assay. The assay principle com-
bines an enzyme immunoassay competition method with
final fluorescent detection. Women included in the study
were examined by ultrasound for viability of the preg-
nancy and accordingly the results were classified into:
viable and non-viable pregnancies. Those with inconclu-
sive sonographic findings were re-examined by ultra-
sound again after two weeks and according to the
findings they were reclassified into viable and non-viable
pregnancies (anembryonic or missed miscarriage).
Women included in this study were followed by ultra-
sound for the viability of the pregnancy till the end of
first trimester and the outcome of their pregnancy were
recorded, while women with exogenous progesterone
support or multiple pregnancies or suspected ectopic
pregnancy or Hydatiform mole were excluded from this
study.
The ultrasound was done by an expert sonographer,
who was blinded to the patients’ data, using Philips HD9
with 2D convex probe 4–9 MHz. Data were collected
and statistically analyzed to detect the relationshipbetween serum progesterone level and viability of the
pregnancy during first trimester.
Sample size justification
Using data of previous studies (Phipps et al. 2000; Hahlin
et al. 1991), setting the type-1 error (α) at 0.05, the power
(1-β) at 0.8 and assuming a 5% dropout rate, the number
of participants needed to produce a statistically accep-
table figure was more than two hundred women.
Statistical analysis
Data were collected, tabulated then statistically analyzed
using Statistical Package for Social Sciences (SPSS);
computer software version (15). Numerical variables
were presented as mean and standard deviation (±SD),
while categorical variables were presented as number
and percentage.
Chi-square test (X2) was used for comparison between
groups as regard qualitative variables. A difference with
p value <0.05 was considered statistically significant,
otherwise it was insignificant. Sensitivity: is the propor-
tional detection of individuals with the disease of inter-
est in the population. Specificity: is the proportional
detection of individuals without the disease of interest in
the population.
Results
Two hundred and Sixty (260) women were hospitalized
due to vaginal bleeding and/or abdominal pain during
first trimester of their pregnancy and were included in
this study. The mean age of the studied population was
32.7 ± 5.1 years (ranged from 18–38 years), their mean
parity was 4.2 ± 5.7 (ranged from 0–9) and the mean
gestational age at progesterone assay was 9.7 ± 0.5 weeks
(ranged from 7–11 weeks), (Table 1).
By the end of first trimester, women included in this
study were classified according to the viability of their
pregnancies into; viable pregnancy group 178 (68.5%)
cases and non-viable pregnancy group (ended by miscar-
riages) 82 (31.5%) cases, (Table 2).
The mean serum progesterone was significantly high
in viable pregnancy group 46.5 ± 7.4 ng/ml (ranged from
18.7 - 86.3 ng/ml), compared with non-viable pregnancy
group 9.9 ± 4.8 ng/ml (ranged from 1.67 - 26.2 ng/ml),
(Chi-square test, p <0.05), (Table 3).
The relations between serum progesterone and mater-
nal age or gestational age of the studied populations
Table 2 Classification of the studied population
according to the viability of the pregnancy
Ultrasound findings Number (n) Percentage (%)
Viable pregnancy group 178 68.5%
Non-viable pregnancy group 82 31.5%
Missed abortion 53 20.4%
Anembryonic (blighted ovum) 29 11.1%
Total number of cases 260 100%
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serum progesterone and past history of early miscarriage
was statistically insignificant (Chi-square test; p >0.05),
(Table 4).
In this study; 6.7% of viable pregnancies had serum
progesterone level <10 ng/ ml, while 20.7% of non-viable
pregnancies had serum progesterone level >10 ng/ml,
the serum progesterone at cut off level 10 ng/ml was
79.3% sensitive to diagnose non-viable pregnancy and
was 93.3% specific to diagnose viable pregnancy. Also, in
this study; 1.1% of viable pregnancies had serum proges-
terone level <20 ng/ ml, while 4.8% of non-viable preg-
nancies had serum progesterone level >20 ng/ml, the
serum progesterone at cut off level 20 ng/ml was 95.1%
sensitive to diagnose non-viable pregnancy and was
98.9% specific to diagnose viable pregnancy (Table 5).
Discussion
Recent studies suggest that serum progesterone mea-
sured in early pregnancy is the most powerful single pre-
dictor of pregnancy outcome in natural conceptions
(Elson et al. 2003; Zainab Ali Abdulla Al 2000; Phipps
et al. 2000). So, this prospective study was designed to
detect the relation between serum progesterone and via-
bility of the pregnancy during the first trimester.
Two hundred and Sixty (260) women were hospita-
lized due to vaginal bleeding and/or abdominal pain dur-
ing the first trimester of their pregnancies and were
included in this prospective study. The mean age of the
studied population was 32.7 ± 5.1 years, the mean gesta-
tional age at progesterone assay was 9.7 ± 0.5 week and
by the end of the first trimester, women included in this
study were classified according to the viability of their
pregnancies into; viable pregnancy group 178 (68.5%)
cases and non-viable pregnancy group (ended byTable 3 The relation between serum progesterone and viabil
Pregnancy outcome Number
(%)
Viable Pregnancy group 178 (68.5%)
Non-viable Pregnancy group 82 (31.5%)miscarriages) 82 (31.5%) cases. The mean serum proges-
terone of the studied population was significantly high
in viable pregnancy group (46.5 ± 7.4 ng/ml) compared
to non-viable pregnancy group (9.9 ± 4.8 ng/ml).
Progesterone level and daily change in human chori-
onic gonadotropin (β-hCG) were determined in the
serum of 307 patients with suspected ectopic pregnancy
by Hahlin et al., and they found that 99% of the viable
intrauterine pregnancies had serum progesterone more
than 30 nmol/l (9.42 ng/ml; 1 nmol/1 = 0.314 ng/ml),
whereas 75% of the ectopic pregnancy and 81% of the
spontaneous abortions had serum progesterone less than
30 nmol/l (9.42 ng/ml), also, serum samples for proges-
terone, inhibin A, hCG, and urine beta-core hCG were
collected from 220 women presented in the first trimes-
ter of pregnancy with complaints of pain, cramping,
bleeding or spotting by Phipps and colleagues, to evalu-
ate whether those biomarkers could predict viable and
non-viable outcomes in pregnancy, and they concluded
that serum progesterone was the most specific single
biomarker for distinguishing viable from non-viable
pregnancies (Hahlin et al. 1991; Phipps et al. 2000).
Although, Lijun & colleagues concluded that serum
progesterone combined with β-hCG measurements, with
a diagnostic accuracy of 85.7%, had the best prognostic
reliability for predicting the outcome of threatened
miscarriage compared to serum progesterone alone or
β-hCG alone (Duan et al. 2011), Daily and colleagues
found that the mean serum progesterone was signifi-
cantly high for viable pregnancies (22.1 ng/ml) com-
pared to non-viable pregnancies (10.1 ng/ml) and they
concluded that a serum progesterone assay alone is
predictive of pregnancy outcome specially during the first
8 weeks of gestation (Daily et al. 1994), also, Zainab Al
Jufairi, found that serum progesterone level was signifi-
cantly high in patients with viable pregnancies (20.48 ±
6.066 ng/ml) compared with patient with non-viable
pregnancies ended by spontaneous abortion (7.78 ± 2.06
ng/ml) and she concluded that the serum progesterone
alone is a reliable marker for prediction of early preg-
nancy failure (Zainab Ali Abdulla Al 2000).
The relations between serum progesterone and ma-
ternal age or gestational age of the studied population
were statistically insignificant; also the relation between
serum progesterone and past history of early miscar-
riage was statistically insignificant.ity of the pregnancy
Serum progesterone (ng/ml) Test used
Mean ± SD (range) P value (significance)
46.5 ± 7.4 (18.7 - 86.3) Chi-square (X2)
9.9 ± 4.8 (1.67 - 26.2) P <0.05 = 0.036
(significant)
Table 4 The relation between serum progesterone and maternal age, gestational age or past history of early
miscarriage
Variables Total number Serum progesterone Test used
(n = 260) (ng/ml) P value
Mean ± SD (Significance)
Maternal age Chi-square (X2)
>35 years old 142 24.62 ± 8.2 P >0.05 = 0.76
< 35 years old 118 18.52 ± 6.8 (Non-significant)
Past history of early miscarriage Chi-square (X2)
Positive 48 12.26 ± 2.3 P >0.05 = 0.07
Negative 212 27.81 ± 5.7 (Non-significant)
Gestational age Chi-square (X2)
>10 weeks gestation 77 16.27 ± 4.7 P >0.05 = 0.27
< 10 weeks gestation 183 26.45 ± 3.9 (Non-significant)
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progesterone level <10 ng/ ml, while 20.7% of non-
viable pregnancies had serum progesterone level >10
ng/ml, the serum progesterone at cut off level 10 ng/ml
was 79.3% sensitive to diagnose non-viable pregnancy
and was 93.3% specific to diagnose viable pregnancy.
Also, in this study; 1.1% of viable pregnancies had
serum progesterone level <20 ng/ ml, while 4.8% of
non-viable pregnancies had serum progesterone level
>20 ng/ml, the serum progesterone at cut off level 20
ng/ml was 95.1% sensitive to diagnose non-viable preg-
nancy and was 98.9% specific to diagnose viable
pregnancy.
Ninety-five (95) pregnant women of 13 weeks or less
were recruited as study group and fourteen (14) normal
pregnant women were recruited as controls, to deter-
mine the role of serum progesterone as a marker of
early pregnancy failure after single assay by Hanita and
colleagues. They found that the serum progesterone
levels were significantly lower in women with non-
viable pregnancies compared with women with viable
pregnancy (10.7 ng/ml versus 45.9 ng/ml; respectively).
Hanita and colleagues, concluded that serum progester-
one can be used as a marker for early pregnancy failure
and at cut-off value of 32.7ng/ml, serum progesteroneTable 5 Relations between serum progesterone cut off levels
Variables
Pregnancy g
Serum Progesterone at cut off level 10 ng/ml
Number of cases with serum progesterone < 10 ng/ml (%)
Number of cases with serum progesterone > 10 ng/ml (%) 166
Serum Progesterone at cut off level 20 ng/ml
Number of cases with serum progesterone < 20 ng/ml (%)
Number of cases with serum progesterone > 20 ng/ml (%) 176had 90% sensitivity with 75% NPV and 92% specificity
with 97% PPV to diagnose early pregnancy failure
(Hanita & Hanisah 2012).
Four hundred and eighty-nine (489) women presenting
with singleton pregnancy, vaginal bleeding and/or ab-
dominal pain in the first 18 weeks of pregnancy were
included in a prospective comparative study was con-
ducted by Al-Sebai et al., to assess the role of a single
maternal serum progesterone measurement in the im-
mediate diagnosis of early pregnancy failure and in the
long term prognosis of fetal viability. They found that
serum Progesterone levels were significantly lower in the
non-continuing and tubal pregnancy groups compared
to threatened-continuing groups and a cut-off level at 45
nmol/l (14.13 ng/ml) was found to differentiate between
the viable pregnancies and the abnormal (non-continu-
ing) pregnancies with 87.6% sensitivity and 87.5% speci-
ficity. Al-Sebai and colleagues concluded that a single
serum progesterone measurement taken in early preg-
nancy is valuable in the immediate diagnosis of early
pregnancy failure and the long term prognosis of viabil-
ity (Al-Sebai et al. 2005).
Also, a prospective study was conducted by Ioannidis
and colleagues, to investigate the relation between early
(14 days after oocyte recovery) serum progesterone assayand viability of the pregnancy
Viable Non-viable
roup (Total number = 178) Pregnancy group (Total number = 82)
12 (6.7%) 65 (79.3% = sensitivity)
(93.3% = specificity) 17 (20.7%)
2 (1.1%) 78 (95.1% = sensitivity)
(98.9% = specificity) 4 (4.8%)
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and receiving rectal progesterone supplements. They
found that the single progesterone assay on day 14 post-
oocyte retrieval was significantly high in women with
on-going pregnancies compared to women with an ab-
normal pregnancy. Ioannidis and colleagues concluded
that single serum progesterone measurement could be a
useful indicator of pregnancy outcome in women under-
going IVF/ICSI treatment (Ioannidis et al. 2005).
Conclusion
Serum progesterone is a reliable marker for early preg-
nancy failure and single assay of its serum level can dif-
ferentiate between viable and non-viable pregnancies.
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